[go: up one dir, main page]

AU5687199A - Use of anti-angiogenic agents for inhibiting vessel wall injury - Google Patents

Use of anti-angiogenic agents for inhibiting vessel wall injury

Info

Publication number
AU5687199A
AU5687199A AU56871/99A AU5687199A AU5687199A AU 5687199 A AU5687199 A AU 5687199A AU 56871/99 A AU56871/99 A AU 56871/99A AU 5687199 A AU5687199 A AU 5687199A AU 5687199 A AU5687199 A AU 5687199A
Authority
AU
Australia
Prior art keywords
vessel wall
angiogenic agents
wall injury
inhibiting vessel
inhibiting
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU56871/99A
Inventor
Charles L Brown
Steve Gorlin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Global Vascular Concepts Inc
Original Assignee
Global Vascular Concepts Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Global Vascular Concepts Inc filed Critical Global Vascular Concepts Inc
Publication of AU5687199A publication Critical patent/AU5687199A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Prostheses (AREA)
  • Materials For Medical Uses (AREA)
  • Media Introduction/Drainage Providing Device (AREA)
AU56871/99A 1998-08-24 1999-08-24 Use of anti-angiogenic agents for inhibiting vessel wall injury Abandoned AU5687199A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US9757998P 1998-08-24 1998-08-24
US60097579 1998-08-24
PCT/US1999/019218 WO2000010552A2 (en) 1998-08-24 1999-08-24 Use of anti-angiogenic agents for inhibiting vessel wall injury

Publications (1)

Publication Number Publication Date
AU5687199A true AU5687199A (en) 2000-03-14

Family

ID=22264134

Family Applications (1)

Application Number Title Priority Date Filing Date
AU56871/99A Abandoned AU5687199A (en) 1998-08-24 1999-08-24 Use of anti-angiogenic agents for inhibiting vessel wall injury

Country Status (2)

Country Link
AU (1) AU5687199A (en)
WO (1) WO2000010552A2 (en)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5504074A (en) 1993-08-06 1996-04-02 Children's Medical Center Corporation Estrogenic compounds as anti-angiogenic agents
US6908910B2 (en) 1993-08-06 2005-06-21 The Children's Medical Center Corporation Estrogenic compounds as anti-mitotic agents
US7772220B2 (en) * 2004-10-15 2010-08-10 Seo Hong Yoo Methods and compositions for reducing toxicity of a pharmaceutical compound
EP1126869B1 (en) * 1998-10-28 2008-09-03 Cornell Research Foundation, Inc. Methods for regulating angiogenesis and vascular integrity using the trk receptor ligands bdnf, nt-3 and nt-4
US7087592B1 (en) 1999-08-23 2006-08-08 Entre Med, Inc. Compositions comprising purified 2-methoxyestradiol and methods of producing same
ATE258441T1 (en) * 1999-09-21 2004-02-15 Inst Cardiologie Montreal LOCAL ADMINISTRATION OF 17-BETA ESTRADIOL TO IMPROVE VASCULAR ENDOTHELIAL FUNCTION AFTER VASCULAR INJURY
WO2001034132A2 (en) * 1999-11-09 2001-05-17 Pharmacia Corporation Use of an aldosterone antagonist for treating restenosis
DE19957342A1 (en) * 1999-11-29 2001-05-31 Gruenenthal Gmbh Treatment of interleukin (IL)-12 mediated illnesses comprises simultaneous administration of thalidomide or analogue and antiinflammatory cytokine
US7182953B2 (en) 1999-12-15 2007-02-27 Celgene Corporation Methods and compositions for the prevention and treatment of atherosclerosis restenosis and related disorders
US6716829B2 (en) 2000-07-27 2004-04-06 Pharmacia Corporation Aldosterone antagonist and cyclooxygenase-2 inhibitor combination therapy to prevent or treat inflammation-related cardiovascular disorders
EP1368009A2 (en) * 2000-07-27 2003-12-10 Pharmacia Corporation Aldosterone blocker therapy to prevent or treat inflammation-related disorders
US6995278B2 (en) 2000-08-18 2006-02-07 Entre Med, Inc. Antiangiogenic agents
US7135581B2 (en) 2000-08-18 2006-11-14 Entremed, Inc. Antiangiogenic agents
US6436629B1 (en) 2000-10-27 2002-08-20 The Regents Of The University Of California Modulating angiogenesis
JP2004537499A (en) * 2000-11-27 2004-12-16 エントレメッド インコーポレイテッド Anti-angiogenic drugs
CZ20031695A3 (en) * 2001-01-12 2004-03-17 Société De Conseils De Recherches Et D'application Pharmaceutical compositions which inhibit vascular proliferation and method of use thereof
DE10115740A1 (en) 2001-03-26 2002-10-02 Ulrich Speck Preparation for restenosis prophylaxis
US6625486B2 (en) 2001-04-11 2003-09-23 Advanced Cardiovascular Systems, Inc. Method and apparatus for intracellular delivery of an agent
AU4239302A (en) * 2001-06-28 2003-01-02 Pfizer Products Inc. Benzoic acid substituted benzopyrans for the treatment of atherosclerosis
WO2003063908A1 (en) * 2002-01-30 2003-08-07 Pharmacia Corporation Aldosterone antagonist and non-steroidal anti-inflammatory agent combination therapy to prevent or treat cardiovascular disorders
KR100995225B1 (en) * 2002-04-22 2010-11-17 재단법인 이쯔우 연구소 Medications for the treatment of vascular diseases
AU2003272378A1 (en) * 2002-09-12 2004-04-30 X-Cell Medical, Inc. Apparatus and method for delivering compounds to a living organism
DE10244847A1 (en) 2002-09-20 2004-04-01 Ulrich Prof. Dr. Speck Medical device for drug delivery
AU2004275693A1 (en) 2003-05-28 2005-04-07 Entremed, Inc. Antiangiogenic agents
US20070110785A1 (en) * 2003-07-03 2007-05-17 Eugene Tedeschi Medical devices with proteasome inhibitors for the treatment of restenosis
WO2005061448A1 (en) * 2003-12-24 2005-07-07 Monash University Compositions and methods for treating vascular conditions
JP2007529426A (en) 2004-03-12 2007-10-25 エントレメッド インコーポレイテッド Anti-angiogenic drugs
WO2006034345A2 (en) 2004-09-20 2006-03-30 Research Development Foundation Avicin-coated stents
MX2007006601A (en) * 2004-12-02 2007-06-19 Abbott Lab Methods for reducing intimal hyperplasia, smooth muscle cell proliferation and restenosis in mammals.
US7286295B1 (en) 2005-11-30 2007-10-23 Sandia Corporation Microoptical compound lens
JP2009530388A (en) 2006-03-20 2009-08-27 エントレメッド インコーポレイテッド Disease-modifying anti-arthritic activity of 2-methoxyestradiol
US8500687B2 (en) 2008-09-25 2013-08-06 Abbott Cardiovascular Systems Inc. Stent delivery system having a fibrous matrix covering with improved stent retention
EP2356998A1 (en) * 2010-02-17 2011-08-17 Université de Liège A pharmaceutical composition for treatment of thrombosis-related diseases comprising a fragment of prolactin (PRL)-growth hormone (GH) - placental lactogen (PL)-family protein
CN113332298A (en) * 2021-05-27 2021-09-03 成都医学院 New use of minocycline as a tyrosine kinase inhibitor

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5096892A (en) * 1988-05-27 1992-03-17 The Children's Medical Center Corporation Arylsulfatase inhibition and potentiation of angiostatic steroids and heparin
ATE190623T1 (en) * 1990-06-11 2000-04-15 Alcon Lab Inc USE OF STEROIDS TO INHIBIT ANGIOGENESIS
US5498238A (en) * 1990-06-15 1996-03-12 Cortrak Medical, Inc. Simultaneous angioplasty and phoretic drug delivery
WO1991019529A1 (en) * 1990-06-15 1991-12-26 Cortrak Medical, Inc. Drug delivery apparatus and method
WO1992015286A1 (en) * 1991-02-27 1992-09-17 Nova Pharmaceutical Corporation Anti-infective and anti-inflammatory releasing systems for medical devices
US5821234A (en) * 1992-09-10 1998-10-13 The Board Of Trustees Of The Leland Stanford Junior University Inhibition of proliferation of vascular smooth muscle cell
CN101007173A (en) * 1993-07-19 2007-08-01 血管技术药物公司 Anti-angiogene compositions and methods of use
US6025334A (en) * 1994-04-28 2000-02-15 Les Laboratoires Aeterna Inc. Extracts of shark cartilage having anti-collagenolytic, anti-inflammatory, anti-angiogenic and anti-tumoral activities; process of making, methods of using and compositions thereof
US5788979A (en) * 1994-07-22 1998-08-04 Inflow Dynamics Inc. Biodegradable coating with inhibitory properties for application to biocompatible materials
AU5959398A (en) * 1997-01-09 1998-08-03 Localmed, Inc. Localized intravascular delivery of antioxidant substances for inhibition of restenosis in recanalized blood vessels
WO1999009982A1 (en) * 1997-08-25 1999-03-04 Harold Brem Prevention of adhesions and excessive scar formation using angiogenesis inhibitors

Also Published As

Publication number Publication date
WO2000010552A3 (en) 2000-11-23
WO2000010552A2 (en) 2000-03-02

Similar Documents

Publication Publication Date Title
AU5687199A (en) Use of anti-angiogenic agents for inhibiting vessel wall injury
GB9800795D0 (en) Prevention of multiple use of limited use devices
HUP0102901A3 (en) Use of n-formyl hydroxylamines as antibacterial agents
GB2339905A8 (en) Use of mass-spectromy for detection mutations
GB0225928D0 (en) Protection of underwater elongate members
PL355101A1 (en) Use of h1
PL346170A1 (en) Short oligonucleotides for the inhibition of vegf expression
TW349560U (en) Improvement for material of partitioned wall
HU9900044D0 (en) Measurement of container wall thickness
GB9805419D0 (en) Treatment of liquids
PL353088A1 (en) Use of lubricants containing polyhydroxy compounds
IL148640A0 (en) Processes for the preparation of sumatriptan and related compounds
GB2333953B (en) Bathtub tray
EP0984315A4 (en) Liquid crystal-aligning agent
GB2325156B (en) Equipment for the removal of cosmetics
GB9901293D0 (en) Waste fitting for shower tray or the like
EP1005340A4 (en) Retinoid antagonists for prevention of surgical adhesions
GB0019350D0 (en) Protection of vessels
GB9812174D0 (en) Prevention of marine fouling
GB0015035D0 (en) Prevention of adhesions
GB9810855D0 (en) Use of compounds
GB9827616D0 (en) Use of PIT emulsions
HUP9904572A3 (en) Flask especially for storing of liquids
PL326575A1 (en) Agent for all-aspect protection of wood
SI1133290T1 (en) Use of inhibitors of acetylcholinesterase for the treatment of deliriums

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase